Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer

被引：0
|
作者：
Fung, A. [1 ]
D'Silva, A. [2 ]
Li, H. [1 ]
Otsuka, S. [1 ]
Bebb, D. G. [2 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Calgary, TBCC Translat Labs, Oncol, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Survival Outliers; Stage IV NSCLC; Metastatic Disease;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-026
引用
收藏
页码：S2077 / S2078
页数：2
相关论文
共 50 条
  • [1] Three-year survival in stage IV non-small cell lung cancer (NSCLC): The importance of metastatic distribution
    Karp, Daniel D.
    Hanneken, Jan M.
    Taylor, Sarah H.
    Men, Taoyan
    Wu, Xifeng
    Pu, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Extending Survival of Stage IV Non-Small Cell Lung Cancer
    Carnio, Simona
    Novello, Silvia
    Mele, Teresa
    Levra, Matteo Giaj
    Scagliotti, Giorgio Vittorio
    SEMINARS IN ONCOLOGY, 2014, 41 (01) : 69 - 92
  • [3] Is survival improving in stage IV non-small cell lung cancer?
    Birnbaum, A. E.
    Ng, T.
    O'Connor, B.
    Plette, A.
    Berz, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] CHEMOTHERAPEUTIC AND TARGETED AGENTS ON SURVIVAL IN STAGE IV NON-SMALL CELL LUNG CANCER
    Yu, Joanne L.
    Simmons, Christine
    Victor, Charles
    Han, Dolly
    Hogeveen, Sophie
    Leighl, Natasha
    Verma, Sunil
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S416 - S416
  • [5] Impact of Metastatic Location on Survival in Stage-IV Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
    Naqash, A. R.
    Jonnalagadda, S.
    Macherla, S.
    Polsani, S.
    Muzaffar, M.
    Cherry, C.
    Karim, N. Abdel
    Walker, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S464 - S464
  • [6] Therapy of non-small cell lung cancer in stage IV
    Deppermann, Karl-Matthias
    Huber, Rudolf M.
    Laack, Eckart
    Reck, Martin
    Serke, Monika
    von Pawel, Joachim
    ONKOLOGIE, 2006, 29 : 15 - 19
  • [7] Surgery for stage IV non-small cell lung cancer?
    Puig, Carlos A.
    Wigle, Dennis
    JOURNAL OF THORACIC DISEASE, 2020, 12 (04) : 1612 - 1614
  • [8] Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer
    Su, Chloe C.
    Wu, Julie T.
    Choi, Eunji
    Myall, Nathaniel J.
    Neal, Joel W.
    Kurian, Allison W.
    Stehr, Henning
    Wood, Douglas
    Henry, Solomon M.
    Backhus, Leah M.
    Leung, Ann N.
    Wakelee, Heather A.
    Han, Summer S.
    JAMA NETWORK OPEN, 2023, 6 (09) : E2335813
  • [9] Clinicopathologic Characteristics And Predictors Of Survival In Stage Iv Non-Small Cell Lung Cancer (nsclc)
    Duma, N.
    Listo, M.
    Osorio, C.
    Zhang, S.
    Kang, M.
    Abu-Ihweij, K.
    Harper, H.
    Gutierrez, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [10] Characteristics Impacting Overall Survival in Stage IV Non-Small Cell Lung Cancer Patients
    Iyer, S.
    Biswas, T.
    Kharouta, M. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E376 - E376
12345